Cutaneous and mucocutaneous leishmaniasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Infectious Disease Clinics of North America

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.idc.2012.03.001PMID 22632640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interventions for Old World cutaneous leishmaniasis.

  2017cited by this paper
• Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases.

  2011cited by this paper
• Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development

  2011cited by this paper
• Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.

  2011cited by this paper
• Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

  2010cited by this paper
• Insulin-like growth factor-I induced and constitutive arginase activity differs among isolates of Leishmania derived from patients with diverse clinical forms of Leishmania braziliensis infection.

  2010cited by this paper
• Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial

  2010cited by this paper
• Interventions for American cutaneous and mucocutaneous leishmaniasis.

  2009influential reference
• Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World

  2009influential reference
• Is real-time polymerase chain reaction (PCR) more useful than a conventional PCR for the clinical management of leishmaniasis?

  2009cited by this paper
• Proven and putative vectors of American cutaneous leishmaniasis in Brazil: aspects of their biology and vectorial competence.

  2009cited by this paper
• Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

  2009cited by this paper
• Treatment of New World cutaneous leishmaniasis – a systematic review with a meta‐analysis

  2008cited by this paper
• Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

  2008cited by this paper
• Differences in transmission seasons as an epidemiological tool for characterization of anthroponotic and zoonotic cutaneous leishmaniasis in northern Afghanistan.

  2008cited by this paper
• Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis

  2008cited by this paper
• Cutaneous leishmaniasis – Authors' reply

  2008cited by this paper
• The Relationship between Leishmaniasis and AIDS: the Second 10 Years

  2008cited by this paper
• Insect vectors of Leishmania: distribution, physiology and their control.

  2008cited by this paper
• Insect vectors of Leishmania: distribution, physiology and their control.

  2008influential reference
• Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network.

  2008cited by this paper
• Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans.

  2007influential reference
• Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.

  2007cited by this paper
• Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis.

  2007cited by this paper
• Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis

  2007cited by this paper
• Treatment of Bolivian mucosal leishmaniasis with miltefosine.

  2007cited by this paper
• Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

  2007cited by this paper
• Clinical manifestations and classification of Old World cutaneous leishmaniasis

  2007cited by this paper
• Cutaneous leishmaniasis.

  2007cited by this paper
• Development of a genetic assay to distinguish between Leishmania viannia species on the basis of isoenzyme differences.

  2006cited by this paper
• Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization

  2006cited by this paper
• Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications

  2006cited by this paper
• Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment.

  2006cited by this paper
• Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis

  2006cited by this paper
• Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony.

  2006cited by this paper
• Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.

  2005cited by this paper
• Cutaneous leishmaniasis in the returning traveler.

  2005cited by this paper
• Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.

  2005cited by this paper
• Culture-Independent Species Typing of Neotropical Leishmania for Clinical Validation of a PCR-Based Assay Targeting Heat Shock Protein 70 Genes

  2004cited by this paper
• Isoenzymatic Analysis of 712 Strains of Leishmania infantum in the South of France and Relationship of Enzymatic Polymorphism to Clinical and Epidemiological Features

  2004cited by this paper
• Leishmaniasis: current situation and new perspectives.

  2004influential reference
• Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases

  2004cited by this paper
• New PCR Assay Using Glucose-6-Phosphate Dehydrogenase for Identification of Leishmania Species

  2003cited by this paper
• Leishmania and HIV co-infection: dermatological manifestations

  2003cited by this paper
• Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99.

  2003cited by this paper
• Post-kala-azar dermal leishmaniasis.

  2003cited by this paper
• Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP.

  2003cited by this paper
• Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil.

  2002cited by this paper
• Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer.

  2002cited by this paper
• Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

  2001influential reference
• Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil.

  2000cited by this paper
• The epidemiology and control of leishmaniasis in Andean countries.

  2000cited by this paper
• Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia

  1999cited by this paper
• Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients.

  1998cited by this paper
• Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis.

  1996cited by this paper
• Monoclonal antibodies for the identification of New World Leishmania species.

  1996cited by this paper
• Discrimination of Leishmania isolates using a limited set of enzymatic loci.

  1995cited by this paper
• POLAR AND SUBPOLAR DIFFUSE CUTANEOUS LEISHMANIASIS IN BRAZIL: CLINICAL AND IMMUNOPATHOLOGIC ASPECTS

  1995cited by this paper
• LEISHMANIASIS RECIDIVA CUTIS IN AMERICAN CUTANEOUS LEISHMANIASIS

  1993cited by this paper
• Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis.

  1990cited by this paper
• Cutaneous leishmaniasis of the New World: diagnostic immunopathology and antigen pathways in skin and mucosa.

  1989cited by this paper
• Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods.

  1987cited by this paper
• American cutaneous and mucocutaneous leishmaniasis.

  1987cited by this paper
• Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis.

  1975cited by this paper
• POST KALA‐AZAR DERMAL LEISHMANIASIS

  1972cited by this paper

• Comparison of efficacy of intravenous versus intramuscular injection meglumine antimoniate in patients of cutaneous leishmaniasis

  2026cites this paper
• Mice mucosal leishmaniasis model shown high parasite load, increased cytotoxicity and impaired IL-10+ T cell response

  2025cites this paper
• Evaluating the Immunomodulatory and Antileishmanial Effects of Thymol-Meglumine Antimoniate Combination Against Leishmania major: Computational and Experimental Analyses.

  2025cites this paper
• Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico Insights

  2025cites this paper
• Nasal Mucosal Leishmaniasis: a Case Report

  2025cites this paper
• Cutaneous Leishmaniasis in Diyala Province from Eastern Part of Iraq during the Period of 2011 to 2021

  2025cites this paper
• Health-related quality of life in Brazilian patients with cutaneous leishmaniasis using EQ-5D

  2025cites this paper
• Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasis.

  2025cites this paper
• Visceral and cutaneous leishmaniasis in a person living with HIV

  2025cites this paper
• Recent advances in the genetic engineering of the Leishmania parasite and anti-cancer properties

  2025cites this paper
• An Update on Clinical and Pathogenic Spectra of Leishmaniasis

  2025cites this paper
• Spatial Epidemiology of Clinical Forms of Cutaneous Leishmaniasis and Treatment Practice: Evidence from Leishmaniasis Research and Treatment Center, Northwest Ethiopia

  2025cites this paper
• Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations

  2025cites this paper
• Dermoscopy of Facial Dermatoses: An Updated Review

  2025cites this paper
• In Vitro Efficacy and Toxicity Assessment of an Amphotericin B Gel for the Treatment of Cutaneous Leishmaniasis

  2025cites this paper
• Cutaneous and Mucocutaneous Leishmaniasis: Perspectives on Immunity, Virulence, and Treatment

  2025cites this paper
• Lesion on the oral mucosa due to American Tegumentary Leishmaniasis and on the lip due to Squamous Cell Carcinoma: a rare case report.

  2025cites this paper
• Molecular Identification and Drug Susceptibility of Leishmania spp. Clinical Isolates Collected from Two Regions of Oaxaca, Mexico

  2025cites this paper
• Leishmaniasis

  2025cites this paper
• Mucocutaneous leishmaniasis with upper airway involvement: A report of three cases.

  2025cites this paper
• Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis.

  2025cites this paper
• Single-nucleotide polymorphisms in genes associated with the vitamin D pathway related to clinical and therapeutic outcomes of American tegumentary leishmaniasis

  2025influential citation
• Infectiousness of Leishmania major to Phlebotomus papatasi: differences between natural reservoir host Meriones shawi and laboratory model BALB/c mice

  2025cites this paper
• The protein map of the protozoan parasite Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis and Leishmania (Leishmania) infantum during growth phase transition and temperature stress.

  2024cites this paper
• Canine leishmaniasis caused by Leishmania tropica in southeastern Iran: a case series study

  2024cites this paper
• Advances in Leishmania Vaccines: Current Development and Future Prospects

  2024cites this paper
• Harnessing the Power of Curcumin: Evaluating Its Efficacy as an Antileishmanial Agent in the Fight Against Leishmaniasis

  2024cites this paper
• Oral leishmaniasis: A scoping review

  2024cites this paper
• Aspidosperma nitidum reduces parasite load and modulates cytokines in BALB/c mice infected with Leishmania (Leishmania) amazonensis

  2024cites this paper
• Uncommon presentation of cutaneous leishmaniasis: late-onset facial involvement after a decade—a rare case report

  2024cites this paper
• Anti-leishmanial activity of Hypericum Scabrum extract against Leishmania major

  2024cites this paper
• Analysis of cutaneous leishmaniasis among military personnel in the Islamic Republic of Iran: a spatiotemporal study between 2018 and 2022, trend forecasting based on ARIMA model

  2024cites this paper
• Perfil clínico-epidemiológico da Leishmaniose Tegumentar Americana período de 2013 a 2022 em São Luís - Maranhão

  2024cites this paper
• Prevalence of Leishmaniasis among Blood Donors: A Systematic Review and Meta-Analysis

  2024cites this paper
• An inhibitor targeting glycosome membrane biogenesis kills Leishmania parasites

  2024cites this paper
• Molecular Diagnosis of Human Cutaneous Leishmaniasis and Identification of the Causative Leishmania Species in Iran: A Narrative Review

  2024cites this paper
• The State of Practicing Traditional Methods and Their Effects on Individuals With Cutaneous Leishmaniasis in Turkey

  2024cites this paper
• Six-Year Study on Cutaneous Leishmaniasis in Al-Muthanna, Iraq: Molecular Identification Using ITS1 Gene Sequencing

  2024cites this paper
• The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

  2024cites this paper
• Review of Leishmaniasis Treatment: Can We See the Forest through the Trees?

  2024cites this paper
• Diagnóstico convencional y molecular de leishmaniasis cutánea y mucocutánea. Una revisión narrativa

  2024cites this paper
• Exploring Bioinformatics Solutions for Improved Leishmaniasis Diagnostic Tools: A Review

  2024cites this paper
• Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline.

  2024cites this paper
• A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules

  2024cites this paper
• Dermatologic manifestations of zoonotic diseases transmitted by dogs: “Spot” could give you spots

  2024cites this paper
• Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp.

  2024cites this paper
• The Impact of Climatological Factors on the Incidence of Cutaneous Leishmaniasis (CL) in Colombian Municipalities from 2017 to 2019

  2024cites this paper
• Machine-Learning- and Structure-Based Virtual Screening for Selecting Cinnamic Acid Derivatives as Leishmania major DHFR-TS Inhibitors

  2023cites this paper
• Psychosocial effects of Cutaneous Leishmaniasis on Patients in Northwestern Ethiopia: A qualitative study

  2023cites this paper
• Honey therapies for dermatological disorders: more than just a sweet elixir

  2023cites this paper
• Cutaneous Leishmaniasis: Physiopathology, Molecular Diagnostic, and Therapeutic Approaches

  2023cites this paper
• Therapeutic response and safety of different treatments for cutaneous leishmaniasis in patients treated at a research center in Medellin - Antioquia, Colombia, between 2016 – 2021

  2023cites this paper
• Mucosal Leishmaniasis: a Rare Infection from Western Nepal

  2023cites this paper
• Case Report: Diffuse Cutaneous Leishmaniasis Successfully Treated with a Combination of Oral Rifampicin and Fluconazole.

  2023cites this paper
• Prevalence of American Tegumentary Leishmaniasis in Brazil – a systematic review and meta-analysis

  2023cites this paper
• Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against Leishmania mexicana

  2023cites this paper
• Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer

  2023cites this paper
• Nanomaterials for Diagnosis, Treatment, and Prevention of Human Cutaneous Leishmaniasis: A Review

  2023cites this paper
• Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs

  2023cites this paper
• Fatty Acid Composition and Metabolism in Leishmania Parasite Species: Potential Biomarkers or Drug Targets for Leishmaniasis?

  2023influential citation
• Unlocking the potential of snake venom-based molecules against the malaria, Chagas disease, and leishmaniasis triad.

  2023cites this paper
• Automated Identification of Cutaneous Leishmaniasis Lesions Using Deep-Learning-Based Artificial Intelligence

  2023cites this paper
• The Effectiveness of Perovskia abrotanoides Extract Topical Formulation on the Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial

  2023cites this paper
• Malaria and leishmaniasis: Updates on co-infection

  2023cites this paper
• Data-driven predictions of potential Leishmania vectors in the Americas

  2023cites this paper
• Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates

  2023cites this paper
• Klinisch‐pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF‐α‐Inhibitoren behandelten Patienten

  2023cites this paper
• Unusual Observations in Leishmaniasis—An Overview

  2023cites this paper
• Exploration of potential inhibitors for autophagy‐related protein 8 as antileishmanial agents

  2022cites this paper
• A Critical Overview of Interleukin 32 in Leishmaniases

  2022cites this paper
• Clinical Cases in Early-Years Pediatric Dermatology

  2022cites this paper
• Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains

  2022cites this paper
• Immune Responses in Leishmaniasis: An Overview

  2022cites this paper
• Leishmania and its relationships with bacteria.

  2022cites this paper
• Present and future: Infectious tropical travel rashes and the impact of climate change

  2022cites this paper
• Epidemiological and histological study of cutaneous leishmaniasis in humans in Al-Najaf Al-Ashraf governorate

  2022cites this paper
• Complex cutaneous infection by Leishmania mexicana treated with miltefosine

  2022cites this paper
• Single nucleotide polymorphisms in genes involved in immune responses and outcome of tegumentary leishmaniasis.

  2022cites this paper
• Data-Driven Predictions of Potential Leishmania Vectors in Latin America

  2022cites this paper
• Clinical-therapeutic follow-up of patients with American cutaneous leishmaniasis caused by different Leishmania spp. in Brazil.

  2022cites this paper
• Leishmania braziliensis causing human disease in Northeast Brazil presents loci with genotypes in long-term equilibrium

  2022cites this paper
• A Review on Cutaneous Leishmaniasis

  2021cites this paper
• Comparison of Three Commonly Used Genetic Markers for Detection of Leishmania Major: An Experimental Study

  2021cites this paper
• Case Report : Lupoid cutaneous leishmaniasis mimicking

  2021cites this paper
• Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

  2021cites this paper
• Identification of potential inhibitors for Sterol C-24 reductase of Leishmania donovani through virtual screening of natural compounds

  2021cites this paper
• Antileishmanial Activity of the Genus Piper: A Systematic Review

  2021cites this paper
• Drug repurposing based novel anti-leishmanial drug screening using in-silico and in-vitro approaches

  2021cites this paper
• In vivo efficacy of meglumine antimoniate-loaded nanoparticles for cutaneous leishmaniasis: a systematic review.

  2021cites this paper
• The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp.

  2021cites this paper
• Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)

  2021cites this paper
• Necropsy findings as a post mortem diagnostic technique for transmissible diseases

  2021cites this paper
• Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology

  2021cites this paper
• miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection

  2021cites this paper
• Systems biology and bioinformatics approaches in leishmaniasis

  2021cites this paper
• Persistent cutaneous canine leishmaniasis caused by Leishmania (Viannia) braziliensis in an area with predominance of Nyssomyia neivai in the state of São Paulo, Brazil.

  2021cites this paper
• Leishmaniasis

  2021cites this paper
• Construction of PX-LmGP63 Using CRISPR-Cas9 as Primary Goal for GP63 gene Knockout in Leishmania major and Leishmanization

  2021cites this paper
• Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama

  2021cites this paper
• In vitro efficacy of polymer coated miltefosine drug against leishmania tropica

  2021cites this paper